Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FUTURE: Talazoparib in Advanced Breast Cancer Selected by RECAP Test
NCT06193525Phase 2Recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2019
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of talazoparib in breast cancer, sponsored by Erasmus MC. Started Sep 2019; status: recruiting.
02
Drugs
talazoparib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06193525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06193525.